Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the “Company” or “Inspira Technologies”), a groundbreaking respiratory support technology company, announced today that Professor Daniel Brodie, an expert in critical care medicine and extracorporeal life support methods, has joined Inspira Technologies’ Scientific Advisory Board.
Prof. Brodie’s appointment to the Scientific Advisory Board follows the appointments of Prof. Eddy Fan and Dr. Stephan Ledot, world-renowned key opinion leaders in intensive care medicine and extracorporeal life support.
Professor Brodie is the Section Chief for Critical Care within the Division of Pulmonary, Allergy and Critical Care Medicine, the Director of the Adult ECMO Program and the Director of the Center for Acute Respiratory Failure at the Columbia University/New York-Presbyterian Hospital.
Professor Brodie is the President-elect of the Extracorporeal Life Support Organization (ELSO) and the chairman of the Executive Committee of the International ECMO Network (ECMONet) – two leading international organizations spearheading scientific knowledge in the field of extracorporeal life support. He is currently on the steering committee of numerous ongoing and upcoming clinical trials in the field. In addition, Prof. Brodie serves as a member of the National Heart, Lung, and Blood Institute’s (NHLBI) Protocol Review Committee for the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network.
Professor Brodie has served as a reviewer in influential scientific journals, including New England Journal of Medicine, The Lancet and The Journal of American Medical Association (JAMA). Prof Brodie has authored more than 300 peer-reviewed publications and book chapters and has delivered nearly 400 invited lectures throughout the world.
Dagi Ben-Noon, Chief Executive Officer of Inspira Technologies, stated: “It is a great honor to have Professor Brodie on Inspira Technologies‘ Scientific Advisory Board. Professor Brodie is a distinguished physician, researcher, and lecturer whose scientific and clinical work is admirable.”
